Covaxin 50% Effective Against Covid, Less Than Initially Thought: Lancet
PUBLISHED ON: November 24, 2021 | Duration: 1 min, 15 sec
Covaxin, one of the main vaccines used in India's coronavirus immunization drive, provides only 50% protection against symptomatic COVID-19, according to a real-world study that suggests the shot is less effective than initially thought.
